PureTech Health PLC (PRTC) Stock Forecast & Price Target
PureTech Health PLC · NASDAQ
$17.38+0.75 (+4.51%)
15-min delayed · Jul 17, 8:00 AM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for PRTC yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $17.38 current
Highest Target—
Average Target—
Lowest Target—
PRTC analyst recommendation trends
86420
Aug
Strong BuyBuyHoldSellStrong Sell
RATING
AUG
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Total
1
As of Aug, 1 of 1 firms rate PRTC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
Top analysts covering PureTech Health PLC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PRTC.
#1
Faisal Khurshid
Jefferies
Buy
No targeton PRTC
Coverage
—
+ Follow
#2
FK
Faisal Khurshid
Leerink Partners
Buy
$45.00+158.9% to target
Coverage
—
+ Follow
PRTC stock forecast FAQ
Who is the most accurate analyst covering PRTC?+
Among analysts who currently cover PRTC, Faisal Khurshid of Jefferies has the strongest overall Quantellect track record. Their current call is Buy.
Have analysts been upgrading or downgrading PRTC lately?+
As of Aug, 1 of 1 firms rate PRTC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PRTC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
